In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Candel Therapeutics Inc (NASDAQ: CADL) closed at $8.80 in the last session, up 1.97% from day before closing price of $8.63. In other words, the price has increased by $1.97 from its previous closing price. On the day, 1.1 million shares were traded. CADL stock price reached its highest trading level at $9.18 during the session, while it also had its lowest trading level at $8.45.
Ratios:
We take a closer look at CADL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 02, 2022, initiated with a Buy rating and assigned the stock a target price of $11.
On November 19, 2021, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $18.
On August 23, 2021, UBS started tracking the stock assigning a Buy rating and target price of $9.UBS initiated its Buy rating on August 23, 2021, with a $9 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 16 ’24 when Manning Paul B bought 1,250,000 shares for $6.00 per share. The transaction valued at 7,500,000 led to the insider holds 1,303,752 shares of the business.
Tyagarajan Seshu sold 20,392 shares of CADL for $92,898 on Nov 29 ’24. The Chief Technology Officer now owns 125,657 shares after completing the transaction at $4.56 per share. On Nov 29 ’24, another insider, Tak Paul Peter, who serves as the Chief Executive Officer of the company, sold 48,847 shares for $4.56 each. As a result, the insider received 222,527 and left with 294,788 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 391384416 and an Enterprise Value of 135071536.
Stock Price History:
Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 57.40%, while the 200-Day Moving Average is calculated to be 42.69%.
Shares Statistics:
According to the various share statistics, CADL traded on average about 3.24M shares per day over the past 3-months and 18689750 shares per day over the past 10 days. A total of 32.13M shares are outstanding, with a floating share count of 26.22M. Insiders hold about 41.04% of the company’s shares, while institutions hold 16.07% stake in the company. Shares short for CADL as of 1730332800 were 1779737 with a Short Ratio of 1.41, compared to 1727654400 on 1587686. Therefore, it implies a Short% of Shares Outstanding of 1779737 and a Short% of Float of 8.06.
